### Comment:
No problem at all. It’s how a lot of shady companies fleece investors: they hide behind stuff that the majority of people don’t know. This isn’t a shady company (I don’t think?) but a lot of penny stocks do this.

### REPLY:
Head of Axovant is quite well respects in the industry. It's got quite a big team behind the drug too (NHS is included, and a few univerisites in the UK as well as a UK biotech that supplies Novartis)

### END.